Updated Guidelines for COPD Management: 2023 GOLD Strategy Report

Article Type
Article
Changed
Tue, 10/29/2024 - 12:19
Display Headline
Updated Guidelines for COPD Management: 2023 GOLD Strategy Report
Author(s)
Muhammad Adrish, MD, MBA, FCCP, FCCM

Click to read more from Pulmonology Data Trends 2023.

References

 

  1. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2023 Report). Published 2023. Accessed June 6, 2023. https://goldcopd.org/2023-gold-report-2/
  2. Celli B et al. Am J Respir Crit Care Med. 2022;206(11):1317. doi:10.1164/rccm.202204-0671PP
  3. Han M et al. Lancet Respir Med. 2013;1(1):43-50. doi:10.1016/S2213-2600(12)70044-9
  4. Klijn SL et al. NPJ Prim Care Respir Med. 2017;27(1):24. doi:10.1038/s41533-017-0022-1
  5. Chan AH et al. J Allergy Clin Immunol Pract. 2015;3(3):335-349.e1-e5. doi:10.1016/j.jaip.2015.01.024
  6. Brusselle G et al. Int J Chron Obstruct Pulmon Dis. 2015;10:2207-2217. doi:10.2147/COPD.S91694 
  7. Salvi SS, Barnes PJ. Lancet. 2009;374(9691):733-743. doi:10.1016/S0140-6736(09)61303-9
  8. Trupin L et al. Eur Respir J. 2003;22(3):462-469. doi:10.1183/09031936.03.00094203
  9. Celli BR et al. Am J Respir Crit Care Med. 2021;204(11):1251-1258. doi:10.1164/rccm.202108-1819PP
  10. Barnes PJ, Celli BR. Eur Respir J. 2009;33(5):1165-1185. doi:10.1183/09031936.00128008
Author and Disclosure Information

Muhammad Adrish, MD, MBA, FCCP, FCCM
Associate Professor
Section of Pulmonary and Critical Care Medicine
Department of Medicine
Baylor College of Medicine
Ben Taub Hospital
Houston, TX

Publications
MDedge Internal Medicine
CHEST Physician
Topics
COPD
Author(s)
Muhammad Adrish, MD, MBA, FCCP, FCCM
Author(s)
Muhammad Adrish, MD, MBA, FCCP, FCCM
Author and Disclosure Information

Muhammad Adrish, MD, MBA, FCCP, FCCM
Associate Professor
Section of Pulmonary and Critical Care Medicine
Department of Medicine
Baylor College of Medicine
Ben Taub Hospital
Houston, TX

Author and Disclosure Information

Muhammad Adrish, MD, MBA, FCCP, FCCM
Associate Professor
Section of Pulmonary and Critical Care Medicine
Department of Medicine
Baylor College of Medicine
Ben Taub Hospital
Houston, TX

Click to read more from Pulmonology Data Trends 2023.

Click to read more from Pulmonology Data Trends 2023.

References

 

  1. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2023 Report). Published 2023. Accessed June 6, 2023. https://goldcopd.org/2023-gold-report-2/
  2. Celli B et al. Am J Respir Crit Care Med. 2022;206(11):1317. doi:10.1164/rccm.202204-0671PP
  3. Han M et al. Lancet Respir Med. 2013;1(1):43-50. doi:10.1016/S2213-2600(12)70044-9
  4. Klijn SL et al. NPJ Prim Care Respir Med. 2017;27(1):24. doi:10.1038/s41533-017-0022-1
  5. Chan AH et al. J Allergy Clin Immunol Pract. 2015;3(3):335-349.e1-e5. doi:10.1016/j.jaip.2015.01.024
  6. Brusselle G et al. Int J Chron Obstruct Pulmon Dis. 2015;10:2207-2217. doi:10.2147/COPD.S91694 
  7. Salvi SS, Barnes PJ. Lancet. 2009;374(9691):733-743. doi:10.1016/S0140-6736(09)61303-9
  8. Trupin L et al. Eur Respir J. 2003;22(3):462-469. doi:10.1183/09031936.03.00094203
  9. Celli BR et al. Am J Respir Crit Care Med. 2021;204(11):1251-1258. doi:10.1164/rccm.202108-1819PP
  10. Barnes PJ, Celli BR. Eur Respir J. 2009;33(5):1165-1185. doi:10.1183/09031936.00128008
References

 

  1. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2023 Report). Published 2023. Accessed June 6, 2023. https://goldcopd.org/2023-gold-report-2/
  2. Celli B et al. Am J Respir Crit Care Med. 2022;206(11):1317. doi:10.1164/rccm.202204-0671PP
  3. Han M et al. Lancet Respir Med. 2013;1(1):43-50. doi:10.1016/S2213-2600(12)70044-9
  4. Klijn SL et al. NPJ Prim Care Respir Med. 2017;27(1):24. doi:10.1038/s41533-017-0022-1
  5. Chan AH et al. J Allergy Clin Immunol Pract. 2015;3(3):335-349.e1-e5. doi:10.1016/j.jaip.2015.01.024
  6. Brusselle G et al. Int J Chron Obstruct Pulmon Dis. 2015;10:2207-2217. doi:10.2147/COPD.S91694 
  7. Salvi SS, Barnes PJ. Lancet. 2009;374(9691):733-743. doi:10.1016/S0140-6736(09)61303-9
  8. Trupin L et al. Eur Respir J. 2003;22(3):462-469. doi:10.1183/09031936.03.00094203
  9. Celli BR et al. Am J Respir Crit Care Med. 2021;204(11):1251-1258. doi:10.1164/rccm.202108-1819PP
  10. Barnes PJ, Celli BR. Eur Respir J. 2009;33(5):1165-1185. doi:10.1183/09031936.00128008
Publications
MDedge Internal Medicine
CHEST Physician
Publications
MDedge Internal Medicine
CHEST Physician
Topics
COPD
Article Type
Article
Display Headline
Updated Guidelines for COPD Management: 2023 GOLD Strategy Report
Display Headline
Updated Guidelines for COPD Management: 2023 GOLD Strategy Report
Disallow All Ads
Content Gating
Open Access (article Unlocked/Open Access)
Alternative CME
Disqus Comments
Default
Eyebrow Default
Slideshow
Gate On Date
Thu, 09/21/2023 - 10:30
Un-Gate On Date
Thu, 09/21/2023 - 10:30
Use ProPublica
CFC Schedule Remove Status
Thu, 09/21/2023 - 10:30
Hide sidebar & use full width
Do not render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Article Slideshow Optional Introduction

Slideshow below. 

The Global Initiative for Chronic Obstructive Lung Disease (GOLD) Strategy Report is an evidence-based strategy document for chronic obstructive pulmonary disease (COPD) diagnosis, treatment, and prevention; the GOLD report is used worldwide as a tool for implementing effective COPD management.1 The annual report reviews the major research publications published from the previous years and provides important updated recommendations for care providers.

The 2023 GOLD report includes several new updates, such as a new proposed definition2; strategies for terminology and taxonomy2; etiotypes for COPD2; screening and risk factor updates1; and vaccination recommendations.1 The ABCD Assessment Tool has been revised to recognize the clinical relevance of exacerbations,3 and the section on Interventional and Surgical Therapies for COPD has been expanded.1 Information on imaging and computed tomography (CT) has been included,1 and issues related to inhaled delivery4 and adherence5 have been addressed. Also included is an expanded role of triple inhaled therapy in select patient populations,6 and the complexity of COPD is also examined— which involves not only cigarette smoking, but other exposures as well.7

Slide
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article
Slide Media
Subscribe to Muhammad Adrish, MD, MBA, FCCP, FCCM